Notification report

Full notification file

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Use of an authorised vectored vaccine for active immunization against feline viral rhinotracheitis, calicivirosis, chlamydiosis, infectious panleucopenia and feline leukaemia in cats.

Proposed period of release:
01/04/2019 to 31/10/2019

Name of the Institute(s) or Company(ies)
Merial, 29, Avenue Tony Garnier, 69007 Lyon, France;

3. Is the same GMO release planned elsewhere in the Community?

Has the same GMO been notified elsewhere by the same notifier?

GMO characterization

GMO is a:
DNA Virus

Identity of the GMO:
The vaccine to be evaluated contains a GMO (vCP97), which is a canarypoxvirus harbouring env and gag genes of FeLV-A virus, already present in vaccines placed on the market in the European Union

Information relating to the recipient or parental organisms from wich the GMO is derived
Common NameGenusSpeciesSubspeciesStrainPathovar
KANAPOXAvipox virusCanarypoxvirus-ALVAC-

European Commission administrative information

Consent given by the Member State Competent Authority:
Not known